We hypothesized that copeptin-based classification would demonstrate superior accuracy, reliability, and feasibility for identifying central diabetes insipidus (CDI), nephrogenic diabetes insipidus (NDI), and primary polydipsia (PP) in pediatric patients. The gene discussed is AVP; the disease is Central diabetes insipidus.